You only have to look to the recent reports of individual impacted by large-scale compounding to realise the dangers posed. Recent Developments In December 2024, Vivani Medical Inc., a pioneering biopharmaceutical company, declared the initiation of its first-in-human clinical trial, LIBERATE-1 at two centers in Australia for investigating the safety, tolerability and complete pharmacokinetic profile of a miniature, GLP-1 (exenatide) implant through the NPM-115 clinical program
There is now good evidence that cytokines and growth factors are key actors in tissue repair and often exert anti-infective activities
Low magnesium
Remember that you're starting at the lowest possible dose, and your body is still adjusting to the medication
By regulating blood sugar curves and signaling the brain's satiety centers, we help you step away from constant food noise and unlock sustainable, efficient fat clearance, ensuring you leave our space feeling lighter, completely re-energized, and in total control of your health